The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
Open accessAbstract
Colorectal cancer (CRC) is a common malignancy with high morbidity and mortality worldwide. To date, chemotherapy plays an important role in the treatment of CRC patients. Multidrug resistance (MDR) is one of the major hurdles in chemotherapy for CRC, and the underlying mechanisms need to be explored. Studies have demonstrated that Wnt/β‐catenin signaling plays a critical role in oncogenesis and tumor development, and its function in inhibiting apoptosis could facilitate tumor chemoresistance. Recent investigations have also suggested the regulatory effects of the Wnt/β‐catenin signaling pathway in response to chemotherapeutic agents in CRC. Here, we particularly focus on reviewing the evidences suggesting the mechanisms of Wnt/β‐catenin signaling in the chemoresistance modulation of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Current studies have shown that activation of the Wnt/β-catenin signaling pathway can mediate CRC resistance to chemotherapy through several pathways, such as upregulation of MDR1, inhibition of apoptosis, maintenance of stem cell dryness, regulation of epithelial-mesenchymal transformation (EMT) and regulation of tumor microenvironment [191].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Li, T., Guo, H., Song, Y., Zhao, X., Shi, Y., Lu, Y., Hu, S., Nie, Y., Fan, D., & Wu, K. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-263 · Cited by 82 · cited 10×
“It has been proven that Wnt/β-catenin signaling modulates the expression of CSC marker genes and plays a role in the self-renewal ability and undifferentiated status of CSCs [43–45].”
BackgroundInfluentialRetractedDermani, F. K., Amini, R., Saidijam, M., Pourjafar, M., Saki, S., & Najafi, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26874 · Cited by 45 · cited 1×
“It was also observed that zerumbone could suppress the stemness properties of CRC by inhibiting the β-catenin signaling pathway [52].”
BackgroundRetractedMiR-150 alleviates EMT and cell invasion of colorectal cancer through targeting Gli1.
Fan, H., Liu, X., Zheng, W.-W., Zhuang, Z.-H., & Wang, C.-D. (2017) · PubMed · doi:10.26355/eurrev_202007_22181 · Cited by 26 · cited 1×
“They have been increasingly implicated in the regulation of cell stemness and EMT, which contribute to drug resistance in colorectal cancer [83, 84].”
BackgroundRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 1×
“Colorectal cancer (CRC), one of the most prevalent malignancies, ranked third in cancer incidence in both genders and remains the second cause of cancer-related deaths in the world [1].”
BackgroundThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931 · cited 1×
“In CRC, loss of E-cadherin is concomitant with the deregulation of the Wnt/β-catenin signaling pathway and has been characterized as a trait of EMT cells [71].”
BackgroundThe Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672 · cited 1×
“differentiate into heterogeneous cell lineages that constitute the tumor [34, 35].”
BackgroundComprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499 · cited 2×
“Wnt/β-catenin signaling pathway is found altered in more than 90% CRC patients, making it a crucial therapeutic target [11].”
BackgroundEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628 · cited 1×
“EMT is a process that allows epithelial cells to undergo remarkable morphologic changes to assume a migratory mesenchymal phenotype characterized by loss of apical basolateral polarity and cell-cell adhesion [56, 57].”
BackgroundComplex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958 · cited 2×
“As one of the major signaling pathways involved in EMT, Wnt/β-catenin signaling converging on activation of transcription factors such as ZEB and Snail was triggered to induce the expression of mesenchymal genes and repress E-cadherin expression [57, 66].”
Background
Cited by
Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target
Zhao, H., Ming, T., Tang, S., Ren, S., Yang, H., Liu, M., Tao, Q., & Xu, H. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01616-7 · Cited by 857
“Studies have shown that Wnt/−catenin signaling plays a key role in tumorigenesis and tumor development, and its function of inhibiting cell apoptosis can promote tumor chemoresistance [38].”
BackgroundDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
DeRango-Adem, E. F., & Blay, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.681477 · Cited by 126
“This pathway regulates cellular behaviors including migration and the formation of tissue structures, and plays a key role in both the formation and progression of cancers, including colorectal carcinoma (Yuan et al., 2020; Bugter et al., 2021; Caspi et al., 2021).”
BackgroundZhang, L., Li, C., & Su, X. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01784-8 · Cited by 96
Zhang, Q., Yang, X., Wu, J., Ye, S., Gong, J., Cheng, W. M., Luo, Z., Yu, J., Liu, Y., Zeng, W., et al. (2023) · Cell Discovery · doi:10.1038/s41421-022-00515-x · Cited by 102
Tewari, D., Bawari, S., Sharma, S., DeLiberto, L. K., & Bishayee, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107876 · Cited by 88
Extracellular matrix: unlocking new avenues in cancer treatment
Lee, J. J., Ng, K. Y., & Bakhtiar, A. (2025) · Biomarker Research · doi:10.1186/s40364-025-00757-3 · Cited by 99
Yang, Y., Yan, X., Li, X., Ma, Y., & Goel, A. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.01.009 · Cited by 75
Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review)
Ji, Y., Lv, J., Sun, D., & Huang, Y. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.5056 · Cited by 78
“The Wnt signaling pathway is divided into two main categories, the non‐canonical (β‐catenin‐independent) and canonical (β‐catenin‐dependent) pathways (9,10).”
BackgroundExosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players
Rizk, N. I., Abulsoud, A. I., Kamal, M. M., Kassem, D. H., & Hamdy, N. Μ. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120325 · Cited by 70
Mechanisms of cancer stem cell therapy
Samadani, A. A., Keymoradzdeh, A., Shams, S., Soleymanpour, A., Norollahi, S. E., Vahidi, S., Rashidy‐Pour, A., Ashraf, A., Mirzajani, E., Khanaki, K., et al. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.08.016 · Cited by 56
Wnt-Independent and Wnt-Dependent Effects of APC Loss on the Chemotherapeutic Response
Stefanski, C. D., & Prosperi, J. R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217844 · Cited by 57
“Up to 90% of colon cancer cases have a mutation in APC, making it an important target in colon cancer therapeutics [6,7].”
BackgroundGharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 64
Alternative splicing modulates cancer aggressiveness: role in EMT/metastasis and chemoresistance
Burman, D. R., Das, S., Das, C., & Bhattacharya, R. (2021) · Molecular Biology Reports · doi:10.1007/s11033-020-06094-y · Cited by 46
Different Roles of Apoptosis and Autophagy in the Development of Human Colorectal Cancer
Orlandi, G., Roncucci, L., Carnevale, G., & Sena, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210201 · Cited by 52
Modulation of Wnt–β-catenin signaling with antibodies: therapeutic opportunities and challenges
O’Brien, S., Chidiac, R., & Angers, S. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.03.008 · Cited by 45
de Oliveira, W. A. A., Moens, S., Laithy, Y. E., van der Veer, B. K., Athanasouli, P., Cortesi, E. E., Baietti, M. F., Koh, K. P., Ventura, J., Amant, F. C., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.705384 · Cited by 44
“Moreover, Wnt directly regulates the transcription of several genes encoding proteins associated with resistance to chemotherapy in diverse cancer types, such as MDR1 (Multidrug resistance protein 1, also known as ABCB1), Survivin, and MMP7 (87).”
BackgroundMing, Y., Deng, Z., Tian, X., Jia, Y., Ning, M., & Shu-hua, C. (2022) · Psychiatry Investigation · doi:10.30773/pi.2021.0370 · Cited by 36
Role of m6A modification in dysregulation of Wnt/β-catenin pathway in cancer
Tabnak, P., Ghasemi, Y., Natami, M., Khorram, R., & Ebrahimnezhad, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114023 · Cited by 36
Clinical Use of Progestins and Their Mechanisms of Action: Present and Future (Review)
Федотчева, Т. А. (2021) · Современные технологии в медицине · doi:10.17691/stm2021.13.1.11 · Cited by 40
Althomali, A., Daghestani, M. H., Almukaynizi, F. B., Al-Zahrani, S. A., Awad, M. A., Merghani, N. M., Bukhari, W. I., Ibrahim, E. M., Alzahrani, S. M., Altowair, N., et al. (2022) · Green Processing and Synthesis · doi:10.1515/gps-2022-0052 · Cited by 36
“Therapies that inhibit Wnt/β-catenin signaling pathways are being performed in many clinical trials to monitor the response of patients, but chemoresistance is a major hurdle [33].”
BackgroundZhang, F., Su, T., & Xiao, M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04750-8 · Cited by 35
“Matrix metalloproteinase-2 (MMP-2), MMP-9, and β-catenin are key proteins that promote tumorigenesis and tumor growth [19, 20].”
BackgroundRetractedCancer stem cells: Signaling pathways and therapeutic targeting
Talukdar, J., Srivastava, T. P., Sahoo, O. S., Karmakar, A., Rai, A. K., Sarma, A., Gogoi, G., Alqahtani, M. S., Abbas, M. A. E., Dhar, R., et al. (2023) · MedComm – Oncology · doi:10.1002/mog2.62 · Cited by 37
Hua, Y., Zhang, K., Sheng, J., Ning, Z., Li, Y., Shi, W., & Liu, L. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119205 · Cited by 42
Sain, A., Sahu, S., & Naskar, D. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002919 · Cited by 35
Progestins as Anticancer Drugs and Chemosensitizers, New Targets and Applications
Федотчева, Т. А., Fedotcheva, N. I., & Shimanovsky, N. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101616 · Cited by 34
“MDR1 is one of the target genes of TCF/LEF and a direct target of the TCF4/β-catenin transcription complex.”
BackgroundInfluentialBalaji, S., Kim, U. R., Muthukkaruppan, V., & Vanniarajan, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119750 · Cited by 36
Seeber, A., Battaglin, F., Zimmer, K., Kocher, F., Baca, Y., Xiu, J., Spizzo, G., Novotny‐Diermayr, V., Rieder, D., Puccini, A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3018 · Cited by 33
“Inappropriate activation of Wnt/b-catenin signaling is a key oncogenic event in a significant subset of colorectal cancers (18) and is associated with tumor cell proliferation and drug resistance (19, 20).”
BackgroundDíaz, M. B. N., Martín, M. J., & Gentili, C. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i26.3027 · Cited by 40
Therachiyil, L., Haroon, J., Sahir, F., Siveen, K. S., Shahab Uddin, M. S., Kuliński, M., Buddenkotte, J., Steinhoff, M. S., & Krishnankutty, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01744 · Cited by 31
The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer
Micallef, I., & Baron, B. (2021) · Non-Coding RNA · doi:10.3390/ncrna7020024 · Cited by 32
“For instance, MMP-7 (matrilysin, a metalloproteinase with prometastatic function) could increase the OXA resistance of colon cancer cells by decreasing the Fas receptor that stimulates cell apoptosis [142,151].”
BackgroundThe Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma
Cierpikowski, P., Leszczyszyn, A., & Bar, J. K. (2023) · Cells · doi:10.3390/cells12162083 · Cited by 29
Citarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Barbagallo, F., Gosti, G., Leonetti, M., Di Fiore, A., Coppola, L., Autilio, T. M., et al. (2023) · Cancers · doi:10.3390/cancers15051471 · Cited by 27
“A recent paper showed that the HH-GLI blockade with GANT61 was able to inhibit NOTCH and WNT/β-catenin in cellular models of CRC [47].”
BackgroundInfluentialFusobacterium nucleatum modulates the Wnt/β-catenin pathway in colorectal cancer development
Mondal, T., Chattopadhyay, D., Mondal, P. S., Das, S., Mondal, A., Das, A., Samanta, S., & Saha, T. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140196 · Cited by 31
Villota, H., Röthlisberger, S., & Pedroza-Díaz, J. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1884730 · Cited by 27
Chai, J. Y., Sugumar, V., Al-Shanon, A. F., Wong, W. F., Fung, S. Y., & Looi, C. Y. (2021) · Cancers · doi:10.3390/cancers13194746 · Cited by 30
“In support of this, various signaling pathways such as transforming growth factor-beta (TGF-β) [60,61], epidermal growth factor receptor (EGFR) [62], mitogen-activated protein kinases (MAPK) [63], and WNT/β-catenin [64,65] have been reported to induce the expression of GLI proteins independent of SMO.”
BackgroundOlguín, J. E., Mendoza-Rodríguez, M., Sánchez-Barrera, C. Á., & Terrazas, L. I. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i2.251 · Cited by 30
Role of circular RNAs in colorectal tumor microenvironment
Ashraf, J. V., Nair, V. S., Saleh, R., & Elkord, E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111351 · Cited by 29
Zhang, W., Peng, C., Yan, J., Chen, P., Jiang, C., Sang, S., Yuan, Y., Hong, Y., & Yao, M. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153844 · Cited by 26
Natural compounds: Wnt pathway inhibitors with therapeutic potential in lung cancer
Shen, X., Gao, C., Li, H., Liu, C., Wang, L., Li, Y., Liu, R., Sun, C., & Zhuang, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1250893 · Cited by 30
“Upregulation of Wnt signaling protects cancer cells from cell cycle arrest or apoptosis which can promote tumor chemoresistance (Yuan et al., 2020).”
BackgroundColorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
Kee, J. X., Yau, J. N. N., Muthuramalingam, R. P. K., Wang, X., Chng, W. H., Lopez‐Sanchez, A., Tay, K. K. W., Deng, L., Gibson, D., Bertrand, H. C., et al. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00041 · Cited by 35
Lim, S. H., Lee, H., Lee, H., Kim, K., Choi, J., Han, J. M., & Min, D. S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01260-9 · Cited by 30
“PA suppresses the expression of proapoptotic tumor suppressor genes, including p53, p21, Egr-1 , and PTEN , while PA upregulates the expression of antiapoptotic survival-related genes, such as Bcl2, cIAP, survivin , hypoxia-inducible factor-1 α ( HIF-1 α ), MMP-2, MMP-9 and COX-2 49 – 51 .”
BackgroundCheng, J., Zhang, R., Yan, M., & Li, Y. (2022) · BMC Cancer · doi:10.1186/s12885-022-09241-9 · Cited by 26
Milan, T. M., Eskenazi, A. P. E., de Oliveira, L. D., SILVA, G. H. D. O., Bighetti‐Trevisan, R. L., Freitas, G. P., & Almeida, L. O. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110773 · Cited by 24
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance
Chen, Z., Wang, G., Guo, M., Zhu, N., Chen, X., Yan, Y., Li, N., & Yu, W. (2024) · Cancer Control · doi:10.1177/10732748241274196 · Cited by 25
“50 Aberrant Wnt signaling plays a signi fi cant role in cancer chemoresistance.”
BackgroundMoreno-Londoño, Á. P., Castañeda‐Patlán, M. C., Sarabia-Sánchez, M. Á., Macías‐Silva, M., & Robles‐Flores, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065252 · Cited by 27
“genes such as survivin, ABC transporters, proteins involved in DNA repair, and proteins involved in cell cycle progression [27,40], which allow cells to survive against cytotoxic stress and re-grow once the intrinsic and extrinsic conditions are optimal.”
BackgroundImtiaz, I. R., Schloss, J. M., & Bugarc̀ić, A. (2025) · Biomolecules · doi:10.3390/biom15030380 · Cited by 23
“Loss of membranous β -catenin has also been linked to poor prognosis in CRC [43,45–47].”
Monge, C., Waldrup, B., Carranza, F., & Velazquez-Villarreal, E. I. (2025) · Cancers · doi:10.3390/cancers17081325 · Cited by 20
“Notably, WNT pathway activation is a hallmark of CRC, with mutations in APC observed in over 80% of cases [19].”
Wei, L., Zhang, Q., Zhong, C., He, L., Zhang, Y., Armaly, A. M., Aubé, J., Welch, D. R., Xu, L., & Wu, X. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13478 · Cited by 24
Self-citationDynamics of Endothelial Cell Diversity and Plasticity in Health and Disease
Larionov, A. A., Hammer, C. M., Fiedler, K., & Filgueira, L. (2024) · Cells · doi:10.3390/cells13151276 · Cited by 24
Epithelial-Mesenchymal Transition in Metastatic Colorectal Cancer
Morgado‐Díaz, J. A., Wagner, M. S., Squiavinato, A. C. M. S., de‐Freitas‐Junior, J. C. M., de Araújo, W. M., Tessmann, J. W., & Rocha, M. R. (2022) · Exon Publications eBooks · doi:10.36255/exon-publications-gastrointestinal-cancers-emt · Cited by 17
Tang, Y., Nan, N., Gui, C.-Z., Zhou, X., Jiang, W., & Zhou, X. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13685 · Cited by 17
“Emerging evidence confirms the aberrant activation of Wnt/β-catenin signalling in a variety of cancers, including CRC, which facilitates tumour malignant progression and resistance to conventional chemotherapy.(4) Importantly, increasing research substantiates that the aberrant Wnt/β-catenin pathway subvert cancer imm…”
BackgroundDiaz, F. C., Waldrup, B., Carranza, F., Manjarrez, S., & Velazquez-Villarreal, E. I. (2025) · Cancers · doi:10.3390/cancers17172833 · Cited by 13
Betson, N., Hajahmed, M., Gebretsadek, T., Ndebele, K., Ahmad, H., Tchounwou, P. B., Spiegelman, V. S., & Noubissi, F. K. (2022) · FASEB BioAdvances · doi:10.1096/fba.2021-00069 · Cited by 14
Rocha, M. R., Castillo‐Medina, Y. K., Coelho, B. M. D. L., Rios, L. L. L., & Morgado‐Díaz, J. A. (2024) · Cell Biology International · doi:10.1002/cbin.12270 · Cited by 16
“In line with these observations (Yuan, Tao, et al., 2020).”
Yang, E.-W., Waldrup, B., & Velazquez-Villarreal, E. I. (2025) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2025.1624797 · Cited by 14
“…WNT signaling pathway is central to colorectal tumorigenesis, with mutations in genes such as APC, CTNNB1, RNF43, and AXIN2 promoting uncontrolled β -catenin activity and transcriptional reprogramming (Cancer Genome Atlas Network, 2012; Farooqi et al., 2019; Yuan et al., 2020; Ullah et al., 2023).”
Barwal, T. S., Sharma, U., Rana, M. K., Bazala, S., Singh, I., Murmu, M., Kapoor, H. S., Thakur, S., Jain, M., & Jain, A. (2022) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2022.103598 · Cited by 12
Cui, Y., Hu, X., Zhang, C., & Wang, K. (2021) · Endocrine · doi:10.1007/s12020-021-02866-z · Cited by 12
Yang, I., Yip, K., Chang, Y., Chen, Y., Huang, C., Tsai, H., Yeh, Y., & Wang, J. (2023) · Cancers · doi:10.3390/cancers15051358 · Cited by 12
“Chemoresistance was correlated with cancer cell stemness in patients with CRC [69,89,90], and patients expressing the CD44 variant appear to present with more aggressive phenotypes of CRC.”
BackgroundLenz, H., Argilés, G., de Jonge, M. J. A., Yaeger, R. D., Doi, T., El-Khoueiry, A. B., Eskens, F. A. L. M., Kuboki, Y., Bertulis, J., Nazabadioko, S., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103729 · Cited by 12
Taank, Y., & Agnihotri, N. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02686-7 · Cited by 12
Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers
Han, W., Fan, Y., & Guan, W. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110632 · Cited by 13
LUCAT1-Mediated Competing Endogenous RNA (ceRNA) Network in Triple-Negative Breast Cancer
Verma, D., Siddharth, S., Yende, A. S., Wu, Q., & Sharma, D. (2024) · Cells · doi:10.3390/cells13221918 · Cited by 11
CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy
Kim, S. J., Kim, S. T., Choi, Y. J., Kim, U. J., & Kang, K. W. (2022) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2022.022 · Cited by 12
“Several studies have suggested that the Wnt/ β -catenin pathway could be a possible therapeutic target for inhibition of cancer progression, metastasis, che-mo-resistance and immunosurveillance evasion (Xi and Chen, 2014; Yuan et al ., 2020).”
Xu, J., Lv, G., Xu, B., & Jiang, B. (2020) · Translational Cancer Research · doi:10.21037/tcr-20-2641 · Cited by 10
“The other is the so-called “non-pump” resistance mechanism, which involves inhibition of apoptosis, detoxification, epithelial-mesenchymal transition (EMT), and an altered tumor microenvironment (26).”
BackgroundPhull, M. S., Jadav, S. S., Gundla, R., & Mainkar, P. S. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113149 · Cited by 12
Tamang, R. L., Kumar, B., Patel, S. M., Thapa, I., Ahmad, A., Kumar, V., Ahmad, R., Becker, D., Bastola, D., Dhawan, P., et al. (2023) · Cells · doi:10.3390/cells12141883 · Cited by 13
“In this regard, the role of Wnt signaling in promoting CRC is well documented, including promoting the CSC phenotype [59].”
BackgroundDeli, H., Vakili-Ghartavol, Z., Asgari, Y., Tavoosidana, G., Eftekhar, E., & Ghahremani, M. H. (2025) · BMC Cancer · doi:10.1186/s12885-024-13392-2 · Cited by 10
Role of ERK1/2 and p38 Protein Kinases in Tumors: Biological Insights and Clinical Implications
Emelyanova, A., Modestov, A., Buzdin, A. A., & Poddubskaya, E. V. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl31317 · Cited by 12
Karimifard, S. A., Salehzadeh‐Yazdi, A., Taghizadeh-Tabarsi, R., & Akbari‐Birgani, S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149420 · Cited by 8
Shin, Y. J., Jo, E. H., Oh, Y., Kim, D. S., Hyun, S., Yu, A.-R., Hong, H. K., & Cho, Y. B. (2023) · Cancers · doi:10.3390/cancers15235531 · Cited by 7
Jiang, H., & Xu, B. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105189 · Cited by 9
Hassan, A. F., Hussein, O., Al-Barazenji, T., Allouch, A., Kamareddine, L., Malki, A. M., Moustafa, A. A., & Khalil, A. A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27002 · Cited by 7
“High expression of vimentin in CRC influences metastasis and promotes resistance to current anti-cancer therapies [59]. similarly, activation of β -catenin is well known to play a critical role in facilitating tumor chemoresistance [60,61].”
BackgroundNie, K., He, Z., & Kong, L.-J. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05935-8 · Cited by 6
“…the Wnt/β-catenin pathway, planar cell polarity vector pathway and Wnt-Ca2+ components, plays a crucial role in cell behavior and tumorigenesis by influencing apoptosis evasion, chemotherapy resistance and autophagy inhibition (Zhao et al. 2022; Petherick et al. 2013; Yuan et al. 2020).”
BackgroundResultRetractedRahjoo, T., Motamedzadeh, A., Ferdosi, F., Dadgostar, E., Aschner, M., Mirzaei, H., Ghesmatpour, S., Nabavizadeh, F., Rahmati‐Dehkordi, F., & Tamtaji, O. R. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-03861-1 · Cited by 6
“Consequently, this mechanism enables cancer cells to endure despite the cytotoxic impacts of chemotherapy (Yuan et al. 2020).”
Majd, M. H., & Guo, X. (2023) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520623666230511124547 · Cited by 6
MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance
Massaro, C., Safadeh, E., Sgueglia, G., Stunnenberg, H. G., Altucci, L., & Dell’Aversana, C. (2020) · Cells · doi:10.3390/cells10010039 · Cited by 6
“In contrast, TRα1 overexpression and Wnt signaling pathway upregulation promote tumor formation in CRC [72] by contributing to escape from chemotherapy-induced apoptosis [73].”
BackgroundAbedi, F., Sahmani, M., Moghbelinejad, S., Azad, M., Rahmani, B., Dibazar, S. P., Khoei, S. G., Goldar, Z. M., & Gheibi, N. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100826 · Cited by 6
Tang, L., Duan, W., Zhang, C., Shi, Y., Tu, W., Lei, K., Zhang, W., Wu, S., & Zhang, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115666 · Cited by 5
Li, C., Huang, Y., Yi, X., Tang, Y., Okita, R., & He, J. (2024) · Translational Cancer Research · doi:10.21037/tcr-24-434 · Cited by 5
Liu, B., Liu, R., Zhang, X., Tian, L., Li, Z., & Yu, J. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111347 · Cited by 8
Self-citationMizoo, T., Oka, T., Sugahara, O., Minato, T., Higa, T., & Nakayama, K. I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae082 · Cited by 5
Spigel, D. R., Wang, J. S., Pronk, L. C., Müskens, B., Teufel, M., Bashir, B., & Burris, H. A. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103730 · Cited by 5
Offin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01129-4 · Cited by 5
Raines, B., Tseng-Rogenski, S. S., Dowdican, A. C., Peris, I., Hinderman, M., Zawacki, K. P., Barrie, K., Onishi, G. H., Dymond, A. M., Luther, T. K., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci193790 · Cited by 5
“Notably, che-motherapies also upregulate PP2A-B56 α –regulated pathways like Wnt/ β -catenin and MAPK to combat chemo-induced cell death (37–39).”
George, M. Y., Ayoub, I. M., Sabry, N. C., Khaled, N., Nasr, M., & Youssef, F. S. (2026) · Food & Function · doi:10.1039/d5fo04462f · Cited by 4
Lee, H.-J., Park, J.-H., Kim, D.-Y., Kim, D., Yi, M.-J., Choi, W.-S., Na, H.-H., 채세현, Oh, Y. T., & Kim, K. (2026) · APOPTOSIS · doi:10.1007/s10495-025-02211-z · Cited by 4
Park, H. A., Edelmann, D., Canzian, F., Seibold, P., Harrison, T. A., Hua, X., Shi, Q., Silverman, A., Benner, A., Macauda, A., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34663 · Cited by 5
“PKP2 is known to be a target of Wnt/β-catenin,(26) whose function in inhibiting apoptosis could possibly facilitate tumor chemoresistance.(27) Functional genomic annotations suggested a plausible role of a variant rs7299220 in oxaliplatin efficacy.”
BackgroundSharma, P., Thuy, N. P., Ansari, I. H., Tripathi, R. M., Kala, M., Elberry, M. H., Sharma, N., & Lee, S. (2026) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-026-03720-8 · Cited by 4
“Additionally, Wnt/β-catenin activation can drive the expression of stemness genes and drug efflux transporters such as ABCB1, whereas Notch signaling in tumor cells often upregulates survival pathways and is linked to resistance to platinum and taxanes [1, 67].”
Beta Catenin Expression in Colorectal Carcinoma and its relation to survival and prognostic factors
Awad, H., Saleh, T., Alhesa, A., Shboul, S. A., Yousef, R., Obeid, A., Qteish, A., & Obeid, J. M. (2024) · Annals of Cancer Research and Therapy · doi:10.4993/acrt.32.10 · Cited by 3
Alimohammadi, M., Kahkesh, S., Khoshnazar, S. M., Khajehpour, H., Farahani, N., Alaei, E., Mafi, A., Hashemi, M., Hedayati, N., Taheriazam, A., et al. (2025) · Gene · doi:10.1016/j.gene.2025.149636 · Cited by 4
ZHUANG, Y., Ning, C., Liu, P., Zhao, Y., Li, Y., MA, Z., Shan, L., Piao, Y., ZHAO, P., & JIN, X. (2022) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2022.028225 · Cited by 5
“LSM12 knockdown exacerbated the apoptosis of CRC cells via inhibiting CTNNB1/TCF-mediated transcription Although it has been reported that the WNT signaling pathway makes CRC cell chemoresistance by inhibiting apoptosis [12], whether the inhibition of transcriptional regulation of CTNNB1/LEF/TCF complex directly leads…”
BackgroundThe molecular characteristics of colorectal cancer: Impact of Ibuprofen and hyperthermia.
Zarghampoor, F., Valibeigi, B., & Behzad‐Behbahani, A. (2023) · PubMed Central · doi:10.22099/mbrc.2023.45296.1802 · Cited by 3
“Investigations have also demonstrated that Wnt/β-catenin signaling could facilitate tumour chemoresistance through the inhibition apoptosis pathway [33].”
BackgroundSegal, J. E., Cronk, J. C., Ball, B., Forbes, G. E., Jackett, K. N., Li, K. P., Osorno, A. M., Montalvan, E. S. A., Browne, A., Lake, J. A., et al. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041609 · Cited by 4
Luminturahardjo, W., Soeatmadji, D. W., Mintaroem, K., Rahajoe, P., & Sandra, F. (2021) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v13i3.1562 · Cited by 2
“(17) Moreover, the loss of cytoplasmic β-Catenin expression was suggested to indicate a poor prognosis of CRC.(18)”
BackgroundInfluentialMugge, L. A., Dang, D. D., Stabingas, K., Keating, G. F., Rossi, C., & Keating, R. F. (2023) · Child s Nervous System · doi:10.1007/s00381-022-05795-y · Cited by 2
“Thus, by extension, APC could be a downregulator of β-catenin [25].”
BackgroundImproving data interpretability with new differential sample variance gene set tests
Rahmatallah, Y., & Glazko, G. V. (2025) · BMC Bioinformatics · doi:10.1186/s12859-025-06117-0 · Cited by 1
“Wnt-β-catenin signaling is essential for the homeostasis of the intestinal epithelium [123] and plays a pivotal role in tumor initiation and development through involvement in cell survival, proliferation, apoptosis and autophagy [124].”
Okotel, M., & Huang, C. (2025) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2025060830 · Cited by 1
Colorectal Cancer Stem Cells: Mechanisms of Resistance and Emerging Therapeutic Targeting Strategies
Alsaeedi, F. A. (2026) · Onco · doi:10.3390/onco6020026 · Cited by 1
“…aberrant Wnt/ β -catenin signalling is common; stabilised nuclear β -catenin accumulation promotes proliferation and survival, while fibroblast-derived exosomes containing Wnt ligands can induce the dedifferentiation of bulk tumour cells into a CSC-like phenotype and enhance chemoresistance [42].”
Ruíz‐García, E., Waldrup, B., Carranza, F., Manjarrez, S., Fernández-Figueroa, E. A., & Velazquez-Villarreal, E. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146195 · Cited by 1
Metadata
- Authors
- Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D.
- Affiliations
- Qingdao Municipal Hospital (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wu, Dapeng
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2020-01
- Volume
- 2020
- Issue
- 1
- Pages
- 9390878-9390878
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- PMC
- PMC7109575
- OpenAlex
- W3012199016
- Cited by
- 131
- References
- 94
- Citations by year
- 2026: 17 · 2025: 19 · 2024: 17 · 2023: 22 · 2022: 26 · 2021: 21 · 2020: 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- BioMed Research International (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Science and Technology Commission of Qingdao Municipality (KJZD-13-39-JCH)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- Wnt/β-catenin signaling, colorectal cancer, chemoresistance, multidrug resistance, apoptosis inhibition, anticancer agents, carcinogenesis
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasm Proteins, Colorectal Neoplasms, Drug Resistance, Neoplasm, beta Catenin, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
